Corcept Therapeutics
CORT
#2839
Rank
C$8.13 B
Marketcap
C$75.76
Share price
-2.22%
Change (1 day)
-27.45%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): C$8.95 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are C$0.76 Billion. In 2025 the company made an earning of C$91.35 Million a decrease over its 2024 earnings that were of C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$8.95 M-90.2%
2025 C$91.35 M-58.84%
2024 C$0.22 B29.65%
2023 C$0.17 B7.2%
2022 C$0.15 B-7.05%
2021 C$0.17 B-5.01%
2020 C$0.18 B12.79%
2019 C$0.16 B26.61%
2018 C$0.12 B74.51%
2017 C$72.58 M548.72%
2016 C$11.18 M-227.03%
2015 -C$8.81 Million-79.58%
2014 -C$43.14 Million-31.79%
2013 -C$63.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.70 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.69 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.55 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.78 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.07 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.19 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$1.93 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$37.72 Million-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.52 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA